KMO and schizophrenia: Serum levels of kynurenine metabolites that lie downstream of KMO (i.e., 3-HK, XA, 3-HANA, and QUINA) were largely reduced in patients affected by schizophrenia, whereas levels of KYNA and ANA, which originate from KYN via KMO-independent reactions, were increased.